NHWA

002262
22.632.35% ( +0.52 )
Delay Closed: Nov 13, 15:00:00

Valuation

Current ValuationThe current P/E ratio is 20.89, within the reasonable range, cheaper than 47.12% of the time in the past 3 years, and the industry ranks 50/222, the industry Median 22.14.

20.89xP/E
Stock price¥22.63Earnings per share¥1.08

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.14x
015304560

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.14x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600276SHHengrui Pharma
35.92x18.32%¥319.05B
002422SZKELUN PHARMA
34.49x10.36%¥67.88B
600085SHTRT
37.16x10.72%¥32.61B
600329SHDRTG
34.09x51.62%¥30.53B
600521SHHuahaipharm
26.64x411.11%¥25.19B
002262SZNHWA
20.89x11.43%¥22.92B
000739SZAPELOA
28.11x11.87%¥22.60B
002773SZKHPG
22.61x--¥20.67B
600867SHTHDB
27.31x53.23%¥14.88B
603456SHJiuzhou Pharma
23.88x17.48%¥14.31B
603707SHNKF
32.18x0.00%¥13.68B
600664SHHPGC
20.56x71.43%¥13.02B
300357SZWolwo Pharma
26.57x18.88%¥11.36B
002019SZYifan Pharmaceutical
34.83x3.03%¥10.84B
600420SHSHYNDEC
23.68x--¥10.69B
600572SHCONBA
22.92x--¥10.47B
688076SHSinopep
39.18x91.51%¥8.74B
000756SZXinhua Pharm
37.13x--¥8.49B
002550SZQianhong Bio-pharma
34.11x--¥7.87B
300119SZRINGPU
22.63x2.44%¥7.63B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.